Fig. 2From: Efficacy and safety of nivolumab for advanced gastric cancer patients with poor performance statusesKaplan–Meier plots of a progression-free survival (PFS) and b overall survival (OS) among study participants. Red line: Good group, Blue line: Poor groupBack to article page